Delivery Order SPE2DB20D1110-SPE2DB25FK01P
Award Date
3/14/25
Potential Completion Date
3/17/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,873.59 Firm Fixed Price Delivery Order contract is for the supply of ACAMPROSATE CALC DR 333 MG TAB 180S, a pharmaceutical product. The contract has an ultimate completion date of March 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,064.52 firm fixed-price delivery order is for the supply of Acamprosate Calcium DR 333 mg tablets, with a period of performance through November 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with ID SPE2DB22D3301|SPE2DB24FX6WP, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,755.18 firm fixed-price delivery order is for the supply of 180 tablets of Acamprosate Calcium delayed-release 333 mg. The contract has a completion date of December 12, 2023 and was awarded on December 11, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $4,173.55 with a completion date of November 22, 2024. The award was issued by the Defense Logistics Agency (DLA), a defense agency, for the delivery of 4566507146 ! ACITRETIN 25 MG CAPSULE 30S. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order with a Firm Fixed Price valued at $1,392.44. The contract is for pharmaceutical and medical supply products to support the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for the company to provide a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for $6,179.97. The contract is a delivery order with a firm fixed price, and it has an ultimate completion date of October 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive...
This is a $1,624.76 firm-fixed price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract covers the supply of pharmaceutical products including capsules, with a period of performance through March 2025. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that supplies medical products and prescription drugs to federal agencies, with a significant Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) with a delivery order valued at $1,443.79. The contract has a period of performance through March 12, 2024 and is a firm fixed-price delivery order, without any set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,451.32 firm fixed-price delivery order contract has an ultimate completion date of March 4, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,764.06 for the supply of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA). The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to...